fluorouracile

Fluorouracile, commonly known by its brand name 5-FU (5-fluorouracil), is a chemotherapy medication used primarily to treat various types of cancer. It belongs to the class of drugs called antimetabolites, which interfere with the synthesis of nucleic acids, thereby inhibiting the growth of rapidly dividing cells such as cancer cells. Fluorouracile is often used to treat cancers of the colon, rectum, breast, stomach, pancreas, and liver, as well as certain skin conditions like basal cell carcinoma.

The drug is typically administered intravenously or topically, depending on the intended use. Intravenous administration is common for systemic cancer treatment, while topical formulations are used for skin cancers. Fluorouracile works by incorporating into RNA and DNA, disrupting their synthesis and leading to cell death. However, since normal cells also divide rapidly, side effects such as bone marrow suppression, gastrointestinal toxicity, and mucositis can occur.

Common side effects of fluorouracile include nausea, vomiting, diarrhea, hair loss, and skin reactions. More serious complications may include severe allergic reactions, neutropenia (low white blood cell count), and thrombocytopenia (low platelet count). The drug may also interact with other medications, such as warfarin, increasing the risk of bleeding.

Dosage and administration are carefully monitored to minimize toxicity while maintaining efficacy. Fluorouracile is often combined with other chemotherapy drugs, such as leucovorin (a folate derivative that enhances its effectiveness) or oxaliplatin, to improve treatment outcomes. Close medical supervision is essential due to its potential for significant side effects.

Resistance to fluorouracile can develop over time, limiting its long-term effectiveness in some patients. Research continues to explore ways to overcome resistance and improve its therapeutic index. As with all chemotherapy agents, fluorouracile should only be used under the guidance of an oncologist or healthcare professional.